MARATTO

article · Future Medicinal Chemistry

Dual VEGFR-2 and EGFR <sup>T790M</sup> inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis

202511 citationsOpen accessHeliopolis University

Abstract

AIM: New phenyldiazene scaffold-linked heterocyclic pyrazole, pyrimidinone, pyrimidinthione, and/or triazine rings have been developed and synthesized. METHODS & RESULTS: showed good ADMET profile. CONCLUSION: inhibition.

Research topics

  • Click Chemistry and Applications
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and biological activity

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/17568919.2025.2453409

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.